Clostridia as live biotherapeutics: can modified Clostridium species enhance disease treatments?

Aleksandra M. Kubiak; Jella van de Laak; Yanchao Zhang; Tom S. Bailey; Luuk Claessen; Philip Hittmeyer; Carlijn Vlaswinkel; Alexsandra Mowday; Ludwig J. Dubois; Jan Theys

doi:10.2217/fmb-2022-0220

Clostridia as live biotherapeutics: can modified Clostridium species enhance disease treatments?

Aleksandra M. Kubiak, Jella van de Laak, Yanchao Zhang, Tom S. Bailey, Luuk Claessen, Philip Hittmeyer, Carlijn Vlaswinkel, Alexsandra Mowday, Ludwig J. Dubois, Jan Theys^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	385-388
Number of pages	4
Journal	Future Microbiology
Volume	18
Issue number	7
Early online date	1 May 2023
DOIs	https://doi.org/10.2217/fmb-2022-0220
Publication status	Published - May 2023

Keywords

biotherapeutics
Clostridium
engineering
prevention
treatment

Access to Document

10.2217/fmb-2022-0220

Cite this

@article{cc5ca4b4a3284b4daa40ddbbb84cb37f,

title = "Clostridia as live biotherapeutics: can modified Clostridium species enhance disease treatments?",

keywords = "biotherapeutics, Clostridium, engineering, prevention, treatment",

author = "Kubiak, {Aleksandra M.} and {van de Laak}, Jella and Yanchao Zhang and Bailey, {Tom S.} and Luuk Claessen and Philip Hittmeyer and Carlijn Vlaswinkel and Alexsandra Mowday and Dubois, {Ludwig J.} and Jan Theys",

year = "2023",

month = may,

doi = "10.2217/fmb-2022-0220",

language = "English",

volume = "18",

pages = "385--388",

journal = "Future Microbiology",

issn = "1746-0913",